Overexpression of peritumoral vascular somatostatin receptors with high affinity for SSTR2-binding analogs, such as octreotide, has been reported in several human tumors (neuroendocrine tumors ...

Molecular imaging, including somatostatin receptor scintigraphy but more so ... mTOR and tyrosine kinase inhibitors may play an increasing role in the management of well-differentiated ...

Because pituitary corticotroph adenomas express somatostatin receptors, somatostatin analogues have been investigated as a potential targeted therapy for the treatment of Cushing's disease.

Ariceum Therapeutics announced that the FDA has cleared its investigational new drug application to commence a Phase I/II ...

Ac-SSO110 (satoreotide) is a first in class Actinium-labelled SSTR2 receptor antagonistPhase I/II SANTANA-225 study on track to enrol patients in Q1 2025BERLIN, Jan. 14, 2025 /PRNewswire/ ...

David Schilansky, newly appointed Chief Financial Officer of Ariceum Therapeutics, commented: I believe Ariceum is one of the most promising biotechs in Europe, gathering fantastic technology, the ...